Lorenzo Sandini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lorenzo Sandini has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Jukka S Jurvelin
2 shared publicationsHeikki Kröger
1 shared publication- Heikki Kröger
Department of Orthopedics and Traumatology, Kuopio University Hospital, Kuopio, Finland
1 shared publication Jari P A Arokoski
1 shared publication- Joonas Sirola
Research Institute of Public Health, University of Kuopio, Kuopio, Finland
1 shared publication - Marjo Tuppurainen
Department of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland
1 shared publication
Latest Publications
- 1 October 2005
- Vol. 32 (10) , 1951-7
Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis.
The inverse relationship between the occurrence of osteoarthritis (OA) and osteoporosis is controversial. Some investigators have found higher bone mineral density (BMD) in the hips, lumbar spine, and other skeletal sites of patients with OA; others have not. We investigated the relationship between BMD and OA. We compared the BMD, bone mineral content (BMC), and projected area of the femoral neck (FN) and trochanter (TR) of 99 women with a validated diagnosis of primary OA from the Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE) cohort, with 2012 controls. The measurements were made twice in women aged 47-59 years in 1989-91, and then repeated in 1994-98. After correction for age, body mass index (BMI), menopausal status, and hormone replacement therapy use before inclusion, we found no significant difference in femoral BMD of the OA patients compared with controls at baseline and at 5-year followup (FN +2.7%, +4.6%, respectively; nonsignificant). However, the BMC was significantly higher in all regions of interest in OA patients at baseline [FN +8.3% (p = 0.004); TR +13.3% (p = 0.017)]. The projected area of FN was also significantly higher at baseline and followup in OA patients (FN +3.7%, +3.9%, respectively; p < 0.001). The projected area of the bones increased in all subjects over the followup period. The BMD decrease rate was higher in OA patients for all regions of interest during followup. Hip BMD of women treated surgically for hip or knee OA was not different from that of healthy controls when measured twice with a 5-year interval. However, at 5-year followup, OA can be accompanied by an increase in bone size or changes in shape, and faster loss of BMD.
- 1 October 2005
- Vol. 32 (10) , 1951-7
Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis.
The inverse relationship between the occurrence of osteoarthritis (OA) and osteoporosis is controversial. Some investigators have found higher bone mineral density (BMD) in the hips, lumbar spine, and other skeletal sites of patients with OA; others have not. We investigated the relationship between BMD and OA. We compared the BMD, bone mineral content (BMC), and projected area of the femoral neck (FN) and trochanter (TR) of 99 women with a validated diagnosis of primary OA from the Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE) cohort, with 2012 controls. The measurements were made twice in women aged 47-59 years in 1989-91, and then repeated in 1994-98. After correction for age, body mass index (BMI), menopausal status, and hormone replacement therapy use before inclusion, we found no significant difference in femoral BMD of the OA patients compared with controls at baseline and at 5-year followup (FN +2.7%, +4.6%, respectively; nonsignificant). However, the BMC was significantly higher in all regions of interest in OA patients at baseline [FN +8.3% (p = 0.004); TR +13.3% (p = 0.017)]. The projected area of FN was also significantly higher at baseline and followup in OA patients (FN +3.7%, +3.9%, respectively; p < 0.001). The projected area of the bones increased in all subjects over the followup period. The BMD decrease rate was higher in OA patients for all regions of interest during followup. Hip BMD of women treated surgically for hip or knee OA was not different from that of healthy controls when measured twice with a 5-year interval. However, at 5-year followup, OA can be accompanied by an increase in bone size or changes in shape, and faster loss of BMD.
- 1 June 2003
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 18 (6) , 1036-1042
Smoking May Impair the Bone Protective Effects of Nutritional Calcium: A Population-Based Approach
Postmenopausal women were randomly selected to investigate the effects of smoking on prevention of bone loss with nutritional calcium. DXA was performed twice, and smoking and calcium intake habits were inquired through the mail in 954 women. Smoking dampened the bone protective effects of nutritional calcium. This may reflect the pathophysiology underlying smoking-induced bone loss postmenopause. This study evaluated the effect of smoking on the bone protective properties of nutritional calcium. Of the random sample of 954 peri- and postmenopausal women selected from the Osteoporosis Risk Factor and Prevention (OSTPRE) study cohort (n = 13,100) in Kuopio, Finland, 182 had smoked at some time (ever smokers) and 772 had never smoked. Women were divided in tertiles according to self-reported dairy nutritional calcium intake (mg/day): < 648 (1st), 648-927 (2nd), > 927 (3rd). Bone mineral density at lumbar spine (LS) and femoral neck (FN) was measured with DXA at baseline in 1989-1991 and at the 5-year follow-up in 1994-1997. In a linear regression model, nutritional calcium intake did not predict annual bone loss in smokers. These results were similar in the subanalysis on 71 current smokers (at both baseline and 5-year measurements) and on 85 past smokers. In never smokers, a statistically significant linear trend was observed between calcium intake and annual bone loss at LS, but at FN only after adjustment for age, weight, hormone replacement therapy (HRT), and other covariates. In analysis of covariance (ANCOVA), no differences in bone loss rate were observed between calcium intake tertiles among smokers. In nonsmokers, the annual bone loss rate was lower in the second (-0.41%) and the third (-0.35%) tertile compared with the first tertile (-0.61%) at LS (p < 0.05) and lower in the third tertile (-0.55%) than in first tertile (-0.72%) at FN after adjustment for age, weight, HRT, and other covariates (p < 0.05). When smokers were added to the nonsmoker group, the differences in bone loss rate between calcium intake tertiles disappeared. In addition, in ANCOVA, the term of interaction between smoking and calcium intake was statistically significant at LS only. In conclusion, smoking seems to impair the bone protective effects of nutritional calcium in postmenopausal women, more clearly in LS than FN.
- 1 June 2003
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 18 (6) , 1036-1042
Smoking May Impair the Bone Protective Effects of Nutritional Calcium: A Population-Based Approach
Postmenopausal women were randomly selected to investigate the effects of smoking on prevention of bone loss with nutritional calcium. DXA was performed twice, and smoking and calcium intake habits were inquired through the mail in 954 women. Smoking dampened the bone protective effects of nutritional calcium. This may reflect the pathophysiology underlying smoking-induced bone loss postmenopause. This study evaluated the effect of smoking on the bone protective properties of nutritional calcium. Of the random sample of 954 peri- and postmenopausal women selected from the Osteoporosis Risk Factor and Prevention (OSTPRE) study cohort (n = 13,100) in Kuopio, Finland, 182 had smoked at some time (ever smokers) and 772 had never smoked. Women were divided in tertiles according to self-reported dairy nutritional calcium intake (mg/day): < 648 (1st), 648-927 (2nd), > 927 (3rd). Bone mineral density at lumbar spine (LS) and femoral neck (FN) was measured with DXA at baseline in 1989-1991 and at the 5-year follow-up in 1994-1997. In a linear regression model, nutritional calcium intake did not predict annual bone loss in smokers. These results were similar in the subanalysis on 71 current smokers (at both baseline and 5-year measurements) and on 85 past smokers. In never smokers, a statistically significant linear trend was observed between calcium intake and annual bone loss at LS, but at FN only after adjustment for age, weight, hormone replacement therapy (HRT), and other covariates. In analysis of covariance (ANCOVA), no differences in bone loss rate were observed between calcium intake tertiles among smokers. In nonsmokers, the annual bone loss rate was lower in the second (-0.41%) and the third (-0.35%) tertile compared with the first tertile (-0.61%) at LS (p < 0.05) and lower in the third tertile (-0.55%) than in first tertile (-0.72%) at FN after adjustment for age, weight, HRT, and other covariates (p < 0.05). When smokers were added to the nonsmoker group, the differences in bone loss rate between calcium intake tertiles disappeared. In addition, in ANCOVA, the term of interaction between smoking and calcium intake was statistically significant at LS only. In conclusion, smoking seems to impair the bone protective effects of nutritional calcium in postmenopausal women, more clearly in LS than FN.